Treating insertional Achilles tendinitis with bio inductive collagen scaffold - Does it improve outcomes? A case series

Q2 Medicine

Journal of Clinical Orthopaedics and Trauma Pub Date : 2025-02-07 DOI:10.1016/j.jcot.2025.102931

Gil Genuth , Lukas D. Iselin

{"title":"Treating insertional Achilles tendinitis with bio inductive collagen scaffold - Does it improve outcomes? A case series","authors":"Gil Genuth , Lukas D. Iselin","doi":"10.1016/j.jcot.2025.102931","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Achilles tendinopathy is a prevalent musculoskeletal condition, affecting approximately 6% of the population at some point in their lives. Insertional Achilles tendinopathy (IAT) is often associated with Haglund deformity (HD), and several surgical interventions exist to address this pathology. Bio-inductive Collagen Scaffolds (REGENETEN™ Smith & Nephew) is a novel bio-inductive scaffold that supports the body's intrinsic healing processes, promoting the growth of new tendon-like tissue. The application of Bio-inductive Collagen Scaffolds in the treatment of IAT and Haglund syndrome represents a relatively recent advancement. This study aims to present our experiences with the use of Bio-inductive Collagen Scaffolds (REGENETEN™) for treating IAT.</div></div><div><h3>Materials and methods</h3><div>This investigation is a retrospective case series involving a single surgeon's experience with eight patients diagnosed with IAT and HD who underwent surgery utilizing Bio-inductive Collagen Scaffolds as an adjunct to standard treatment modalities between 2022 and 2023. The study was classified as a service evaluation by the local ethics committee. Data collected included age, comorbidities, complications, and AOFAS hindfoot scores pre-operatively and at six months postoperatively. Pre-operative and six-month postoperative MRI scans were similarly analysed.</div></div><div><h3>Results</h3><div>The mean age of participants was 52.6 years (range: 43–65), with 50% of the cohort being female. The average follow-up duration was 10 months (range: 8–14 months). The AOFAS (Ankle-Hindfoot) score improved from 62.3 (range: 57–70) prior to surgery to 89.6 (range: 82–94) at six months post-surgery (p < 0.05). All MRI evaluations indicated complete healing by six months post-operation. All patients regained full preoperative function, averaging nine months after surgery (range: 6–11 months). No wound-related complications or other adverse events were noted during the follow-up period.</div></div><div><h3>Conclusions</h3><div>The application of Bio-inductive Collagen Scaffolds appears to enhance patient outcomes without increasing complication rates. Future research is warranted to more comprehensively assess the benefits of Bio-inductive Collagen Scaffolds in the management of IAT and HD.</div></div>","PeriodicalId":53594,"journal":{"name":"Journal of Clinical Orthopaedics and Trauma","volume":"63 ","pages":"Article 102931"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Orthopaedics and Trauma","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S097656622500027X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Achilles tendinopathy is a prevalent musculoskeletal condition, affecting approximately 6% of the population at some point in their lives. Insertional Achilles tendinopathy (IAT) is often associated with Haglund deformity (HD), and several surgical interventions exist to address this pathology. Bio-inductive Collagen Scaffolds (REGENETEN™ Smith & Nephew) is a novel bio-inductive scaffold that supports the body's intrinsic healing processes, promoting the growth of new tendon-like tissue. The application of Bio-inductive Collagen Scaffolds in the treatment of IAT and Haglund syndrome represents a relatively recent advancement. This study aims to present our experiences with the use of Bio-inductive Collagen Scaffolds (REGENETEN™) for treating IAT.

Materials and methods

This investigation is a retrospective case series involving a single surgeon's experience with eight patients diagnosed with IAT and HD who underwent surgery utilizing Bio-inductive Collagen Scaffolds as an adjunct to standard treatment modalities between 2022 and 2023. The study was classified as a service evaluation by the local ethics committee. Data collected included age, comorbidities, complications, and AOFAS hindfoot scores pre-operatively and at six months postoperatively. Pre-operative and six-month postoperative MRI scans were similarly analysed.

Results

The mean age of participants was 52.6 years (range: 43–65), with 50% of the cohort being female. The average follow-up duration was 10 months (range: 8–14 months). The AOFAS (Ankle-Hindfoot) score improved from 62.3 (range: 57–70) prior to surgery to 89.6 (range: 82–94) at six months post-surgery (p < 0.05). All MRI evaluations indicated complete healing by six months post-operation. All patients regained full preoperative function, averaging nine months after surgery (range: 6–11 months). No wound-related complications or other adverse events were noted during the follow-up period.

Conclusions

The application of Bio-inductive Collagen Scaffolds appears to enhance patient outcomes without increasing complication rates. Future research is warranted to more comprehensively assess the benefits of Bio-inductive Collagen Scaffolds in the management of IAT and HD.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Orthopaedics and Trauma Medicine-Orthopedics and Sports Medicine

CiteScore

4.30

自引率

0.00%

发文量

181

审稿时长

92 days

期刊介绍： Journal of Clinical Orthopaedics and Trauma (JCOT) aims to provide its readers with the latest clinical and basic research, and informed opinions that shape today''s orthopedic practice, thereby providing an opportunity to practice evidence-based medicine. With contributions from leading clinicians and researchers around the world, we aim to be the premier journal providing an international perspective advancing knowledge of the musculoskeletal system. JCOT publishes content of value to both general orthopedic practitioners and specialists on all aspects of musculoskeletal research, diagnoses, and treatment. We accept following types of articles: • Original articles focusing on current clinical issues. • Review articles with learning value for professionals as well as students. • Research articles providing the latest in basic biological or engineering research on musculoskeletal diseases. • Regular columns by experts discussing issues affecting the field of orthopedics. • "Symposia" devoted to a single topic offering the general reader an overview of a field, but providing the specialist current in-depth information. • Video of any orthopedic surgery which is innovative and adds to present concepts. • Articles emphasizing or demonstrating a new clinical sign in the art of patient examination is also considered for publication. Contributions from anywhere in the world are welcome and considered on their merits.